69 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:14am
of rebates and return reserves, as well as provisions for litigation and restructuring. 1) Rebates and Return Reserves Takeda has recognized a provision … Rebate Program, the U.S. Medicare Part-D Rebate Program and the U.S. Commercial Managed Care Program. 2) Provisions for Litigation Provisions
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:03am
of rebates and return reserves, as well as provisions for litigation and restructuring. 1) Rebates and Return Reserves Takeda has recognized a provision … Drug Rebate Program, the U.S. Medicare Part-D Rebate Program and the U.S. Commercial Managed Care Program. 2) Provisions for Litigation Provisions
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
31 May 22
Current report (foreign)
12:00am
primarily of rebates and return reserves, as well as provisions for litigation and restructuring. 1) Rebates and Return Reserves Takeda has recognized … . Medicaid Drug Rebate Program, the U.S. Medicare Part-D Rebate Program and the U.S. Commercial Managed Care Program. 2) Provisions for Litigation Provisions
6-K
TAK
Takeda Pharmaceutical Co
15 Feb 19
Current report (foreign)
6:06am
and litigation costs
155.2
Amortization of acquired intangible assets
1,806.2
Integration and acquisition costs
585.1
Reorganization costs
286.2 … related to the unwind of inventory fair value adjustments
42.8
Litigation costs related to patent infringement
155.2
Depreciation
317.8
Non GAAP
6-K
TAK
Takeda Pharmaceutical Co
27 May 20
Current report (foreign)
6:05am
risks, stable supply, and litigation and other legal matters, IT-security and information management, etc.), the person(s) in charge of each function … of provisions for litigation and restructuring.
1) Rebates and Return Reserves
Takeda has recognized a provision related mainly to sales rebates and returns
6-K
EX-99.1
70pvt3v27fk
11 Jan 22
Current report (foreign)
6:02am
6-K
aklb8c50uj 7z8q
2 Feb 24
Current report (foreign)
6:16am
6-K
uvatgkktmqursa0pq8n
1 Feb 24
Current report (foreign)
6:06am
20FR12B
xx9pwk2t4dcj
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
0z123ee2
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
f7k8o6c 5733g3ms
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
6-K
svx oxqif2iu
9 May 24
Current report (foreign)
6:01am
DRS/A
EX-1.2
st693twz
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
EX-1.2
zxlg21
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
EX-1.2
juji 2p16bcff5l8pg
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
6-K
h0rey vicq0i
31 May 22
Current report (foreign)
6:20am